AI CuratorAI-generated
Research summary · AI summary · not yet reviewedCell studyNot reportedPeer review unconfirmed
Inflammatory Response in Human Oligodendroglioma and Schwann Cells
IL-1β treatment in Human Oligodendroglioma and Schwann cells increased neuroinflammatory markers and decreased myelin Basic Protein and synaptophysin levels. It also downregulated autophagy markers, but treatment with Ibuprofen and Flurbiprofen countered some of IL-1β's harmful effects.
- Most relevant to
- Neurologist, Immunologist
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
These findings highlight the potential inflammatory mechanisms in neurodegenerative conditions like MS and suggest that certain drugs may mitigate these effects.
What this does not prove
Results are based on in vitro studies and do not establish clinical efficacy in human MS.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-18
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Neuroinflammation
Original sources
Supporting passages (7)
subjectsCells
research categoriesNeuroinflammation
publication date2026-09-18
interventionIbuprofen and Flurbiprofen
comparatorIL-1β
findingsIL-1β increased neuroinflammatory markers like TNFα, MyD88, βAPP, COX-2, and IL-6, as well as transcription factors like NFκB and STAT in HOG and Schwann cells, which in turn regulate the expression of other cytokines, resulting in the activation of the self-perpetuating Cytokine Cycle.
limitationsTitle: Interleukin-1β-Induced Inflammatory Signaling and Myelin-Related Alterations in Oligodendroglia and Schwann Cells in Multiple Sclerosis: Modulatory Effects of Ibuprofen and Flurbiprofen.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.